Arrowhead Pharmaceuticals
ARWR
#1750
Rank
S$15.78 B
Marketcap
S$112.03
Share price
-0.01%
Change (1 day)
451.03%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2026 (TTM): -S$0.21 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are S$0.62 Billion. In 2025 the company made an earning of S$0.44 Billion, an increase over its 2024 earnings that were of -S$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.21 Billion-145.52%
2025 S$0.44 B-157.5%
2024 -S$0.78 Billion112.45%
2023 -S$0.37 Billion87.79%
2022 -S$0.2 Billion-20.1%
2021 -S$0.25 Billion67.59%
2020 -S$0.15 Billion-347.53%
2019 S$58.6 M-245.59%
2018 -S$40.26 Million-13.17%
2017 -S$46.37 Million-52.28%
2016 -S$97.17 Million-16.57%
2015 -S$0.12 Billion30.32%
2014 -S$89.36 Million171.62%
2013 -S$32.9 Million16.56%
2012 -S$28.23 Million107.53%
2011 -S$13.61 Million
2008 -S$47.91 Million-8.07%
2007 -S$52.12 Million70.37%
2006 -S$30.59 Million122.51%
2005 -S$13.75 Million147.41%
2004 -S$5.56 Million2002.28%
2003 -S$0.27 Million-85.61%
2002 -S$1.84 Million1371.97%
2001 -S$0.13 Million-13.45%
2000 -S$0.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.54 B-16,353.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-S$4.02 Billion 1,847.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.24 B-219.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion-26.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.12 B-644.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-S$0.12 Billion-45.44%๐Ÿ‡บ๐Ÿ‡ธ USA